Cholecystectomy Except by Laparoscope w/ MCC DRG Reimbursement

Trials evaluating perioperative management strategies for patients undergoing open cholecystectomy with major complications (MCC), such as protocols for timing of surgery after biliary sepsis or optimization of comorbid conditions; these studies enroll high-acuity inpatients including those with acute cholecystitis complicated by sepsis, gangrene, or organ dysfunction and compare early versus delayed operative timing or different preoperative optimization bundles. This research is relevant to providers and payers because it targets reduction of in-hospital morbidity, length of stay, and intensive care utilization in the DRG population with MCC, which directly affects resource use and reimbursement costs.
Comparative effectiveness studies of surgical approach and intraoperative techniques for non-laparoscopic cholecystectomy in high-risk patients, comparing variations such as subtotal cholecystectomy, bile duct exploration strategies, and use of intraoperative imaging or drains; these trials focus on older adults and patients with anatomic difficulty or severe inflammation that precludes laparoscopic repair. Findings inform choices that may reduce reoperation, postoperative complications, and readmissions among DRG 414 cases, helping clinicians select techniques that balance safety and cost-effectiveness for complex biliary disease.
Post-discharge and chronic care outcome studies assessing recovery trajectories, readmission risk prediction, and transitional care interventions for patients discharged after open cholecystectomy with major complications; cohorts include patients with extended ICU stays, post-op infections, or biliary injury who are tracked for 30–90 day outcomes, functional status, and healthcare utilization. Results are highly relevant to payers and facilities because they identify targets for reducing readmissions and downstream expenditures (such as home health needs or repeat hospitalizations) and guide post-acute care planning for this high-cost DRG group.

Trials evaluating perioperative management strategies for patients undergoing open cholecystectomy with major complications (MCC), such as protocols for timing of surgery after biliary sepsis or optimization of comorbid conditions; these studies enroll high-acuity inpatients including those with acute cholecystitis complicated by sepsis, gangrene, or organ dysfunction and compare early versus delayed operative timing or different preoperative optimization bundles. This research is relevant to providers and payers because it targets reduction of in-hospital morbidity, length of stay, and intensive care utilization in the DRG population with MCC, which directly affects resource use and reimbursement costs.
Comparative effectiveness studies of surgical approach and intraoperative techniques for non-laparoscopic cholecystectomy in high-risk patients, comparing variations such as subtotal cholecystectomy, bile duct exploration strategies, and use of intraoperative imaging or drains; these trials focus on older adults and patients with anatomic difficulty or severe inflammation that precludes laparoscopic repair. Findings inform choices that may reduce reoperation, postoperative complications, and readmissions among DRG 414 cases, helping clinicians select techniques that balance safety and cost-effectiveness for complex biliary disease.
Post-discharge and chronic care outcome studies assessing recovery trajectories, readmission risk prediction, and transitional care interventions for patients discharged after open cholecystectomy with major complications; cohorts include patients with extended ICU stays, post-op infections, or biliary injury who are tracked for 30–90 day outcomes, functional status, and healthcare utilization. Results are highly relevant to payers and facilities because they identify targets for reducing readmissions and downstream expenditures (such as home health needs or repeat hospitalizations) and guide post-acute care planning for this high-cost DRG group.

OpenPayer

Summary & Overview

Cholecystectomy Except by Laparoscope without C.D.E. with MCC: Inpatient Reimbursement Overview

DRG 414 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes